Short answer · Medically reviewed summary · Last updated: 2026-05-08
Factor V Deficiency (also known as Owren's disease or parahemophilia) is primarily caused by mutations in the F5 gene, which prevent the body from producing sufficient or functional Factor V protein needed for blood clotting. While the hereditary form is a genetic condition, acquired Factor V Deficiency can also occur due to autoimmune responses where the body mistakenly attacks its own clotting factors. What causes Factor V Deficiency? The primary cause of congenital Factor V Deficiency is an autosomal recessive mutation in the F5 gene located on chromosome 1.
Factor V Deficiency (also known as Owren's disease or parahemophilia) is primarily caused by mutations in the F5 gene, which prevent the body from producing sufficient or functional Factor V protein needed for blood clotting. While the hereditary form is a genetic condition, acquired Factor V Deficiency can also occur due to autoimmune responses where the body mistakenly attacks its own clotting factors.
The primary cause of congenital Factor V Deficiency is an autosomal recessive mutation in the F5 gene located on chromosome 1. This gene provides instructions for making the Factor V protein, which acts as a crucial "accelerator" in the blood coagulation cascade. When this protein is missing or defective, the blood cannot form stable clots efficiently, leading to bleeding symptoms. Unlike many other clotting disorders, the severity of Factor V Deficiency symptoms does not always correlate perfectly with the level of Factor V in the blood.
Yes, the congenital form follows an autosomal recessive inheritance pattern. This means an individual must inherit two copies of the mutated gene—one from each parent—to manifest the disorder. If a person inherits only one copy, they are typically an asymptomatic carrier. In rare cases, Factor V Deficiency can be acquired later in life, which is distinct from the genetic form.
Understanding the etiology requires distinguishing between the two primary pathways of the disease:
Researchers are currently investigating gene therapy techniques to potentially correct the F5 gene defect. Additionally, studies are ongoing to better understand why some patients with very low Factor V levels remain asymptomatic, while others with similar levels experience significant bleeding episodes.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.